ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Shares in Issue
Live Quote
 
 

ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, its principle place of business is in the United Kingdom. 

The Total Number of shares with nominal value 0.1p in issue is 1,059,562,609 (As of 05 January 2012).  The percentage of securities not in public hands is approximately 4%. The shareholders who hold more than 3% are as follows:

The information below was last updated on 01 February 2012.

 

Shareholders


Number of Shares

Percentage of Total

Pershing Nominees Limited


33,659,049

   3.18%

Peter Crowson

52,854,868

   4.99%

 Directors

45,110,711   4.6%